GlassScriptPhysician profile
Kevin Monahan
NPI 1407317571
$6,432.47
in general payments reported to CMS, 2019-2025
11 companies · $3,369 in 2025
The $3,369 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,064 · 2025: $3,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,886 · Travel and Lodging: $2,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,885.91 |
| Travel and Lodging | $2,546.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,731.51 | 2024-2025 | Pro, T2 Alpha, Pangea |
| Arthrex, INC. | $1,132.94 | 2025 | |
| Depuy Synthes Sales INC. | $499.58 | 2025 | Na, Va-Lcp |
| Innovation Technologies INC | $173.79 | 2025 | Irrisept |
| Medtronic, INC. | $151.54 | 2024 | Infinity Occipitocervical Upper Thoracic System |
| Zimmer Biomet Holdings, INC. | $147.52 | 2025 | |
| Si-Bone, INC. | $147.44 | 2025 | |
| Lifenet Health | $122.08 | 2025 | Pliafx Flo, Allograft Vmis Delivery System |
| Illuminoss Medical, INC. | $122.03 | 2025 | |
| Axogen | $112.76 | 2025 | |
| Mid-Atlantic Surgical Systems, LLC | $91.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Monahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.